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Objective: The aim of this study was to determine the effects of nociceptin/orphanin FQ peptide receptor (N/OFQ receptor) 
antagonist on orofacial pain induced by experimental tooth movement in rats.
Methods: A total of 36 male Sprague-Dawley rats weighing 200–300 g were divided into six groups: a control group, force 
group, force+saline intraperitoneal group, force+saline periodontal group, force+UFP-101 ([Nphe1,Arg14,Lys15]N/OFQ-NH2; 
antagonist for N/OFQ receptor) intraperitoneal group, and force+UFP-101 periodontal group. Closed coil springs were ligated 
between the upper incisors and first molar to exert an orthodontic force (40 g) between the teeth. Injectable administration 
dosages were 30 µl saline or 30 µl saline containing 0.03 mg/kg UFP-101. Following the injections, orofacial pain levels were 
assessed through directed face grooming (mouth wiping). Statistical analyses were performed in SPSS 17.0 (Statistical Package 
for the Social Sciences) and p values less than 0.05 were considered as statistically significant. 
Results: Orofacial pain levels were significantly higher in the force group than in the control group. Orofacial pain levels differed 
significantly between the force group, force+saline periodontal group and force+UFP-101 periodontal group, but were similar 
between the control group, force+UFP-101 intraperitoneal group and force+saline intraperitoneal group. Moreover, orofacial 
pain levels did not differ between the force group, force+saline intraperitoneal group and force+UFP-101 intraperitoneal group.
Conclusions: Periodontal, but not intraperitoneal, administration of UFP-101 could alleviate orofacial pain induced by 
experimental tooth movement in rats, suggesting that periodontal N/OFQ receptors participate in orofacial pain induced by 
experimental tooth movement.
(Aust Orthod J 2016; 32: 206-210)
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Introduction
Orofacial pain induced by tooth movement, simply 
designated as orthodontic pain, is commonly 
encountered in daily orthodontic practice1,2 as a 
result of inflammatory responses.3-5 Although the 
exact mechanisms underlying the pain response are 
still poorly understood, it has been documented that 
many neuropeptides and pro-inflammatory mediators 
participate in the modulation of pain.6 Investigating 
the mechanisms by which these molecules generate 
orthodontic pain could help unravel intrinsically 
complex underlying mechanisms.
Nociceptin/orphanin FQ (N/OFQ), an endogenous 
opioid peptide, plays an important role in orofa-
cial pain.7 A large body of evidence indicates that 
N/OFQ produces either pro- or anti-nociceptive ef-
fects, depending on the dosage and site of administra-
tion.8,9 Its anti-nociceptive effects at the spinal level 
prevail over its pro-nociceptive effects at the supraspi-
nal level,8 which was supported by the finding that 
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N/OFQ-receptor-knockout mice displayed stronger 
nociceptive responses against inflammatory pain.10 
UFP-101, [Nphe1,Arg14,Lys15]N/OFQ-NH
2
, a potent 
and selective antagonist of N/OFQ receptors, could 
competitively inhibit various N/OFQ actions.11,12 
Therefore, it is conceivable that blocking N/OFQ 
receptors with UFP-101 could exacerbate pain. A pre-
vious study revealed that N/OFQ was upregulated in 
the trigeminal nucleus in rats following experimental 
tooth movement,7 suggesting a potential role of N/
OFQ in the perception of orthodontic pain. To date, 
however, the effects of blocking N/OFQ receptors 
(through applying UFP-101) on orofacial pain in-
duced by experimental tooth movement in rats are 
still largely unknown. Therefore, the aim of this study 
was to determine the effects of UFP-101 on orofacial 
pain following tooth movement.
Methods
Animals
In total, 36 male Sprague-Dawley rats (200–300 
g) were used in the present study. The animals 
were housed in standard transparent plastic cages 
containing soft bedding, and had free access to food 
and water. The room was kept temperature-controlled 
at 25oC and had a 12/12h light dark cycle. Measures 
were taken to minimise animal numbers and distress. 
The methods of investigating pain in animals adhered 
to the guidelines of The International Association for 
the Study of Pain.13
Fixed Ni-Ti alloy closed-coil springs were ligated 
between the left maxillary first molar and upper 
incisors, which delivered 40 g force (measured by a 
force meter) to generate mesial movement of the 
maxillary molars. 
Drug administration
Following general anaesthesia with 4% chloral hydrate 
(peritoneal injection; 3 mg/kg), force loading and 
subsequent drug administration was performed. The 
rats were randomly divided into six groups: a control 
group, a force group, a force+saline intraperitoneal 
group, a force+UFP-101 intraperitoneal group, a 
force+saline periodontal group, and a force+UFP-101 
periodontal group. The spring appliances were 
mounted in the mouths of the control group but 
inactivated so that no forces were applied. The spring 
appliances were mounted and activated in the force 
groups so that a force of 40 g was delivered. Each 
rat in the force+saline intraperitoneal group received 
an intraperitoneal injection of 30 µl saline one day 
after force loading. Each rat in the force+UFP-101 
intraperitoneal group received an intraperitoneal 
injection of 30 µl UFP-101 solution (0.03 mg/kg) 
after the force loading. Each rat in the force+saline 
periodontal group received a periodontal injection 
of 30 µl saline one day after the force loading. Each 
rat in the force+UFP-101 periodontal group received 
a periodontal injection of 30 µl UFP-101 solution 
(0.03 mg/kg) after the force loading. For each rat, the 
periodontal injections were performed at the following 
six sites with 5 µl administered at each site (totalling 
30 µl): buccal, palatal and distal sites of the incisors; 
buccal, palatal and mesial sites of the first molars.
Evaluation of pain
Orthodontic pain levels were assessed through 
directed face-grooming (mouth wiping) according to 
the protocols established in a previous study.5 Four 
hours after drug administration, the rats were placed 
into transparent plastic cages (30 cm × 30 cm × 30 
cm) with 45-dB of background noise. Face-grooming 
activities were video-taped for three sessions (10 
minutes for each). The videos were analysed by two 
authors who were blinded to the animal groups. The 
mouth wiping time was recorded and considered as 
a surrogate for orofacial pain generated following 
experimental tooth movement. 
Statistics
A Rank Sum Test was used for statistical analyses in 
SPSS 17.0 (Statistical Package for the Social Sciences). 
A p value less than 0.05 was considered as statistically 
significant.
Results
As presented in Figure 1 and Table I, the results 
showed that pain levels were significantly higher in the 
force group (median: 62.3; interquartile range: 58.5) 
than in the control group (median: 11.3; interquartile 
range: 25.7), indicating that orthodontic force could 
induce orofacial pain in rats.
As displayed in Figure 2 and Table I, it was found 
that pain levels were similar between the force group 
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(median: 62.3; interquartile range: 58.5) and both 
of the intraperitoneal groups (saline – median: 44.7; 
interquartile range: 29.7 – and UFP-101 – median: 
49.9; interquartile range: 89.4), while pain levels 
differed between the force group (median: 62.3; 
interquartile range: 58.5) and both of the periodontal 
groups (saline – median: 85.8; interquartile range: 
73.9 – and UFP-101 – median: 33.2; interquartile 
range: 29.5). In addition, pain levels did not differ 
between the force+saline intraperitoneal group 
(median: 44.7; interquartile range: 29.7) and the 
force+UFP-101 intraperitoneal group (median: 49.9; 
interquartile range: 89.4). In contrast, pain levels were 
significantly higher in the force+UFP-101 periodontal 
group (median: 33.2; interquartile range: 29.5) than 
in the force+saline periodontal group (median: 85.8; 
interquartile range: 73.9). 
Discussion
Orofacial pain is commonly encountered in patients 
during orthodontic treatment particularly after the 
placement and adjustment of appliances. It has been 
well documented that orthodontic pain is associated 
with pressure, ischaemia, inflammation and oedema.14 
It has been further shown that released molecules15 
(substance P and calcitonin-related gene peptide 
(CGRP)) are closely associated with orthodontic 
tooth movement. Clinically, the initial orthodontic 
pain and discomfort peaks during the first three 
days following appliance activation. Pain begins to 
fade after one week.16 Therefore, the present research 
chose to compare pain levels between the different 
animal groups on the first day after the application 
of force. Experiment tooth movement produced an 
obvious animal behaviour characterised by directed 
face-grooming.17 Similar directed grooming responses 
have been reported as a result of noxious stimulation 
applied to rats.18-20 A previous study found that both 
systemic and local administrations of morphine 
could relieve orthodontic pain in rats.5 Moreover, 
local administration exerts a better analgesic effect 
than systemic administration following experimental 
animal tooth movement, which supports the clinical 
use of peripheral anti-nociceptive medicine in the 
control of orthodontic pain.5 
Similar to other classical opioid ligands, N/OFQ is 
an endogenous opioid peptide whose receptor is 
Figure 1. Orofacial pain levels (mouth wiping time, seconds) in 
the force group and the control group following experimental tooth 
movement. The plus and minus error bars stand for maximal and 
minimal values, respectively. The box stands for interquartile range and 
the horizontal line through the box stands for the median value.
Figure 2. Orofacial pain levels (mouth wiping time, seconds) in saline 
periodontal group, UFP-101 periodontal group, saline intraperitoneal 
group and UFP-101 intraperitoneal group. The plus and minus error 
bars stand for maximal and minimal values, respectively. The box stands 
for interquartile range and the horizontal line through the box stands for 
the median value. 
Table I. Mouth wiping (pain level) following experimental tooth movement in rats.
i.p.: intraperitoneal
p.: periodontal
Group Control Force Saline i.p. group Saline p. group UFP-101 i.p. group UFP-101 p. group
Median 11.2900 62.2850 44.6800 85.7950 49.8500 33.1500
Interquartile range 25.685 58.505 29.655 73.9225 89.3775 29.52
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located in the central but also the peripheral nervous 
system. The peptide plays an important role in the 
modulation of pain and gastrointestinal function.9 
The effects are, however, controversial. The effects 
of N/OFQ administration could vary because of 
dosage and the site of administration. Intrathecal 
(IT) blockade of N/OFQ receptors was not shown to 
alleviate acute pain in previous rat models.18 However, 
IT injection of N/OFQ receptor antagonists was 
able to reverse the nociceptive response of electro-
acupuncture in inflammatory rat models.21 In 
addition, the use of a peripheral N/OFQ receptor 
agonist could produce an anti-nociceptive effect in 
capsaicin-induced inflammatory pain models. A 
previous study revealed that N/OFQ was upregulated 
in the trigeminal nucleus in rats following tooth 
movement.7 However, the exact role of N/OFQ in the 
regulation of orthodontic pain following experimental 
tooth movement is unknown. In the present study, 
UFP-101 was used to block N/OFQ, both locally 
and systemically. In Carvalho’s research,22 the 0.03 
mg/kg and 0.3 mg/kg administration of UFP-101 
significantly reduced mortality after surgery involving 
cecal ligation and puncture (CLP), but dosages over 
0.1 mg/kg increased the mortality of rats. Therefore, 
a dosage of 0.03 mg/kg for UFP-101 was used in the 
present study.
The present study found that the periodontal 
administration of UFP-101 relieved orthodontic pain 
in rats, indicating that peripheral N/OFQ produces 
pro-nociceptive effects. The anti-nociceptive effects 
of N/OFQ at the spinal level prevailed over its pro-
nociceptive effects at the supraspinal level.8 Therefore, 
it is conceivable that systemic blocking N/OFQ 
receptors with UFP-101 produced pro-nociceptive 
effects on orthodontic pain. However, it was found 
that the systemic administration of UFP-101 had no 
effect on orthodontic pain. This could be attributed to 
the anti-nociceptive effects of UFP-101 at periodontal 
sites, which may offset the net pro-nociceptive effects 
of UFP-101 produced at the spinal and supraspinal 
levels. This would hold provided that UFP-101 
reached periodontal, spinal and supraspinal sites 
following systemic administration. The possibility 
suggests that N/OFQ may produce local effects in 
addition to both spinal and supraspinal effects.
In conclusion, it is suggested that N/OFQ receptors 
mediate pro-nociceptive effects at periodontal sites on 
orthodontic pain and that periodontal, rather than 
systemic, blocking of N/OFQ receptors with UFP-
101 could relieve orthodontic pain in rats.
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